Neural Regeneration Research ›› 2024, Vol. 19 ›› Issue (7): 1463-1472.doi: 10.4103/1673-5374.387967

Previous Articles     Next Articles

α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil#br#

Yunying Yang1, Zhentao Zhang1, 2, *   

  1. 1Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; 2TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, Hubei Province, China
  • Online:2024-07-15 Published:2023-11-28
  • Contact: Zhentao Zhang, MD, PhD, zhentaozhang@whu.edu.cn.
  • Supported by:
    This work was supported by the National Natural Science Foundation of China, Nos. 82271447, 81771382; the National Key Research and Development Program of China, No. 2019YFE0115900; and the “New 20 Terms of Universities in Jinan”, No. 202228022 (all to ZZ).

Abstract: α-Synuclein is a protein that mainly exists in the presynaptic terminals. Abnormal folding and accumulation of α-synuclein are found in several neurodegenerative diseases, including Parkinson’s disease. Aggregated and highly phosphorylated α-synuclein constitutes the main component of Lewy bodies in the brain, the pathological hallmark of Parkinson’s disease. For decades, much attention has been focused on the accumulation of α-synuclein in the brain parenchyma rather than considering Parkinson’s disease as a systemic disease. Recent evidence demonstrates that, at least in some patients, the initial α-synuclein pathology originates in the peripheral organs and spreads to the brain. Injection of α-synuclein preformed fibrils into the gastrointestinal tract triggers the gut-to-brain propagation of α-synuclein pathology. However, whether α-synuclein pathology can occur spontaneously in peripheral organs independent of exogenous α-synuclein preformed fibrils or pathological α-synuclein leakage from the central nervous system remains under investigation. In this review, we aimed to summarize the role of peripheral α-synuclein pathology in the pathogenesis of Parkinson’s disease. We also discuss the pathways by which α-synuclein pathology spreads from the body to the brain.

Key words: aggregation, autonomic nervous system, barrier receptors, body fluid circulation, in situ generation, Parkinson’s disease, phosphorylation, propagation, synucleinopathies, α-synuclein, α-synuclein fibrils